Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences today released its Appendix 4E and annual financial report for the year ending 30th June 2016.
Please click here to view the ASX announcement.
Anatara presents at Spotlight CEO Investor Session, McDonald’s Antibiotic Commitment Ahead of Schedule, CARB-X Global Partnership Read more »